Riley Rodgers
Past Finalist, Mentor & Judge @ MassChallenge
San Francisco, United States
Riley Rodgers is a Series A investor at MassChallenge in San Francisco focused on Genetics and Health Care. Riley Rodgers is the Principal at Valia Ventures.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Riley Rodgers invests in
Stages Riley Rodgers invests in
Countries Riley Rodgers invests in
Investment Focus
Industry
- Genetics 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Health Diagnostics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Shield Bio
|
At Shield, we’re ensuring that antibiotic resistance doesn’t become more deadly than cancer.In 2050 more people will be dying of antibiotic resistant pathogens than cancer. Infections that were once treatable with a simple oral antibiotics are now requiring complex, painful treatments and resulting in serious health complications for patients.Gonorrhea is one such infection, having become resistant to over 10 different antibiotics, they have only one treatment that is still effective and resistance to this has already begun to emerge. With 820,000 new infections every year in the US, antibiotic resistance will spread quickly, which is why the CDC has resistant gonorrhea at an urgent threat level, the highest level available.Shield's novel genomic testing platform enables STI clinics to identify the antibiotic resistant strains of gonorrhea and other pathogens that their patients have, so they can select the correct antibiotics and halt the spread of antibiotic resistance. | $8M / Series A / May 23, 2018 |
Co-Investors
About MassChallenge
MassChallenge works with founders developing solutions across sectors such as healthcare, climate, food systems, financial services, and security. It connects startups with corporate partners, investors, industry experts, and policymakers to facilitate business development and market entry. MassChallenge provides programming that includesmentorship, training, and access to resources that assist with product development, go-to-market strategy, and scaling operations. Its ecosystem integrates founders, advisors, and institutional partners to support company growth and advancement within complex industries.
MassChallenge Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Antonio Procopio
Judge
|
|||
Cait Brumme
Acting Chief Executive Officer
|
|||
Camila Lecaros
Managing Director
|
|||
Charlotte Jepps
Expert & Accelerator Program Judge
|
|||
Chris Houlihan
Chief Growth Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Riley Rodgers invest in?
Riley Rodgers invests primarily in Genetics, Health Care and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Riley Rodgers last invest?
The most recent investment recorded for Riley Rodgers closed in May 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
